LivaNova Plc (LIVN)
63.57
-0.49
(-0.76%)
USD |
NASDAQ |
Dec 11, 12:22
LivaNova EPS Diluted (Quarterly): 0.4856 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovoCure Ltd. | -0.333 |
| Abbott Laboratories | 0.9146 |
| ResMed, Inc. | 2.373 |
| Tactile Systems Technology, Inc. | 0.3646 |
| Perspective Therapeutics, Inc. | -0.3495 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 26.78M |
| Revenue (Quarterly) | 357.75M |
| Total Expenses (Quarterly) | 330.97M |
| Enterprise Value | 3.338B |
| Gross Profit Margin (Quarterly) | 68.44% |
| Profit Margin (Quarterly) | 7.49% |
| Earnings Yield | -6.31% |
| Normalized Earnings Yield | -7.035 |